Boston Scientific Logo
Back to main page Print Complete
ICD Product Longevity
U.S. Reason for Out of Service

CRM Product Performance Report Q4 2011

TELIGEN DR

Models E110/E111/F110/F111



U.S. Summary
U.S. Registered Implants: 60,000
U.S. Approval Date: May 2008
U.S. Estimated Active Implants: 52,000
U.S. Normal Battery Depletions: 28
U.S. Unconfirmed Reports of
Premature Battery Depletion
: 1
U.S. Malfunctions:60
Without Compromised Therapy:23
With Compromised Therapy:37
Battery Depletions and Malfunctions


Malfunctions Only
U.S. Survival Probability
 Year 1 2 34 56 78 910
Non Advisory Population

Registered Implants: 29000
Depletions and Malfunctions(%)
(Confidence Interval)
99.92
(-0.1/+0.0)
99.87
@ 20 mo.

(-0.1/+0.1)
 Malfunctions Only(%)
(Confidence Interval)
99.95
(-0.0/+0.0)
99.92
@ 20 mo.

(-0.1/+0.0)
  Effective Sample Size 11471879

Subpectoral Implant 2009*

Registered Implants: 24000
Depletions and Malfunctions(%)
(Confidence Interval)
99.88
(-0.1/+0.0)
99.77
(-0.1/+0.1)
99.68
(-0.1/+0.1)
99.68
@ 38 mo.

(-0.1/+0.1)
 Malfunctions Only(%)
(Confidence Interval)
99.89
(-0.1/+0.0)
99.83
(-0.1/+0.0)
99.82
@ 38 mo.

(-0.1/+0.0)
99.82
@ 38 mo.

(-0.1/+0.0)
  Effective Sample Size 26764184592226442

*Devices subject to an advisory. Refer to the Advisories for more details.